Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Odongo, Charles O ^a,b   Bisaso, Kuteesa R ^a   Kitutu, Freddy ^a   Obua, Celestino ^c   Byamugisha, Josaphat ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b GULU UNIVERSITY   (Uganda)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Intermittent preventive treatment; Malaria treatment; Pregnant women; Sulphadoxine pyrimethamine; Uganda

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT;

ADULT; ARTICLE; COMMUNITY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; POPULATION; PREGNANT WOMAN; PREVALENCE; PUBLIC HEALTH; STRUCTURED QUESTIONNAIRE; UGANDAN; ATTITUDE TO HEALTH; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PREGNANCY; TIME FACTOR; UGANDA; YOUNG ADULT;

ADULT; AMBULATORY CARE FACILITIES; ANTIMALARIALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALARIA; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; TIME FACTORS; UGANDA; YOUNG ADULT;

EID: 84929165016     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0702-7     Document Type: Article

References (34)

1. WHO. World malaria report 2012. Geneva, Switzerland: World Health Organization; 2013.
2. Dellicour S, Tatem A, Guerra C, Snow R, ter Kuile F. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.
3. Uganda total fertility rate - demographics. Available from [ www.indexmundi.com/uganda/total-fertility-rate.html ]. Last accessed October 15 2014.
4. Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P, Talisuna A, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg. 2006;75:219-25.
5. Dellicour S, Hall S, Chandramohan D, Greenwood B. The safety of artemisinins during pregnancy: a pressing question. Malar J. 2007;6:15.
6. National Malaria Control Programme. Uganda National Malaria Control Policy 2011. Kampala, Uganda: Ministry of Health; 2011.
7. Yeka A, Achan J, D'Alessandro U, Talisuna A. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis. 2009;9:448-52.
8. Omo-Aghoja LO, Abe E, Feyi-Waboso P, Okonofua FE. The challenges of diagnosis and treatment of malaria during pregnancy in low resource settings. Acta Obstet Gynaecol Scand. 2008;87:693-6.
9. Batwala V, Magnussen P, Hansen KS, Nuwaha F. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J. 2011;10:372.
10. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, et al. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis. 2003;3:99-102.
11. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW T, et al. Malaria misdiagnosis in Uganda - implications for policy change. Malar J. 2009;8:66.
12. Kyabayinze DJ, Asiimwe C, Nakanjako D, Nabakooza J, Counihan H, Tibenderana JK. Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar J. 2010;9:200.
13. Kinney MV, Kerber KJ, Black RE, Cohen B, Nkumah F, Coovadia H, et al. Sub-Saharan Africa's mothers, newborns and children: where and why do they die? PLoS Med. 2010;7:e1000294.
14. Pell C, Menaca A, Were F, Afrah NA, Chatio S, Taylor LM, et al. Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One. 2013;8:e53747.
15. Simkhada B, Teijlingen ER, Porter M, Simkhada P. Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008;619:244-60.
16. Ministry of Health. Health Sector Strategic Plan II, 2005/6-2009/10. Kampala, Uganda: Uganda Printing and Publishing Corporation; 2005.
17. Mbonye A, Birungi J, Yanow S, Magnussen P. Prescription patterns and drug use among pregnant women with febrile illnesses in Uganda: a survey in out-patient clinics. BMC Infect Dis. 2013;13:237.
18. Sangare LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, et al. Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J. 2011;10:152.
19. Odongo CO, Bisaso RK, Byamugisha J, Obua C. Intermittent use of sulfadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic. Malar J. 2014;13:399.
20. Ribera JM, Hausmann-Muela S, D'Alessandro U, Grietens KP. Malaria in pregnancy: what can the social sciences contribute? PLoS Med. 2007;4:e92.
21. Cochran GW. Sampling techniques. 2nd ed. New York: John Wiley and Sons, Inc; 1963.
22. De Beaudrap P, Turyakira E, White LJ, Nabasumba C, Tumwebaze B, Muehlenbachs A, et al. Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malar J. 2013;12:139.
23. Lauristen JM. EpiData entry, data management and basic statistical analysis system. Odense, Denmark: EpiData Association; 2006. URL: http://www.epidata.dk.
24. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
25. Anderson TW, Goodman LA. Statistical inference about Markov chains. Annals Math Stat. 1957;28:89-109.
26. Muenz LR, Rubinstein LV. Markov models for covariate dependence of binary sequences. Biomet. 1985;41:91-101.
27. Yeung S, White NJ. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005;10:121-38.
28. Ocan M, Bwanga F, Bbosa GS, Bagenda D, Waako P, Ogwal-Okeng J, et al. Patterns and predictors of self-medication in northern Uganda. PLoS One. 2014;9:e92323.
29. Vialle-Valentin CE, Lecates RF, Zhang F, Desta AT, Ross-Degnan D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Trop Med Int Health. 2012;17:211-22.
30. Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters D, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. 2008;102:1067-74.
31. Patouillard E, Hanson KG, Goodman CA. Retail sector distribution chains for malaria treatment in the developing world; a review of the literature. Malar J. 2010;9:50.
32. Awor P, Wamani H, Bwire G, Jagoe G, Peterson S. Private sector drug shops in intergreted community case management of malaria, pneumonia and diarhoea in children in Uganda. Am J Trop Med Hyg. 2012;87:92-6.
33. Chaturvedi HK, Mahanta J, Panday A. Treatment seeking for febrile illness in north-east India: an epidemiological study in the malaria endemic zone. Malar J. 2009;8:301.
34. Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D. A comparison of prescription practices between public and private sector physicans in Uganda. East Afr Med J. 2004:S12-6. PMID 15125111.